Impact of comorbid substance use and infectious and non-communicable diseases in a cross-sectional study, Thailand

References

• Aharonovich, E., Hasin, D. S., Brooks, A. C., Liu, X., Bisaga, A., & Nunes, E. V. (2006). Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug and Alcohol Dependence, 81(3), 313–322. https://doi.org/10.1016/j.drugalcdep.2005.08.003
   PubMed Web of Science ®Google Scholar
• Becker, J. B., Koob, G. F., & Gottesman, M. M. (2016). Sex differences in animal models: Focus on addiction. Pharmacological Reviews, 68(2), 242–263. https://doi.org/10.1124/pr.115.011163
   PubMed Web of Science ®Google Scholar
• Caiaffa, W. T., Zocratto, K. F., Osimani, M. L., Martínez, P. L., Radulich, G., Latorre, L., Muzzio, E., Segura, M., Chiparelli, H., Russi, J., Rey, J., Vazquez, E., Cuchi, P., Sosa-Estani, S., Rossi, D., & Weissenbacher, M. (2011). Hepatitis C virus among non-injecting cocaine users (NICUs) in South America: Can injectors be a bridge? Addiction, 106(1), 143–151. https://doi.org/10.1111/j.1360-0443.2010.03118.x
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2014). Suicide Prevention. https://www.cdc.gov/ViolencePrevention/suicide/index.html
   Google Scholar
• Chiang, S. C., Chan, H. Y., Chang, Y. Y., Sun, H. J., Chen, W. J., & Chen, C. K. (2007). Psychiatric comorbidity and gender difference among treatment-seeking heroin abusers in Taiwan. Psychiatry and Clinical Neurosciences, 61(1), 105–111. https://doi.org/10.1111/j.1440-1819.2007.01618.x
   PubMed Web of Science ®Google Scholar
• Copersino, M. L., Fals-Stewart, W., Fitzmaurice, G., Schretlen, D. J., Sokoloff, J., & Weiss, R. D. (2009). Rapid cognitive screening of patients with substance use disorders. Experimental and Clinical Psychopharmacology, 17(5), 337–344. https://doi.org/10.1037/a0017260
   PubMed Web of Science ®Google Scholar
• Copersino, M. L., Schretlen, D. J., Fitzmaurice, G. M., Lukas, S. E., Faberman, J., Sokoloff, J., & Weiss, R. D. (2012). Effects of cognitive impairment on substance abuse treatment attendance: Predictive validation of a brief cognitive screening measure. The American Journal of Drug and Alcohol Abuse, 38(3), 246–250. https://doi.org/10.3109/00952990.2012.670866
   PubMed Web of Science ®Google Scholar
• Cruickshank, C. C., & Dyer, K. R. (2009). A review of the clinical pharmacology of methamphetamine. Addiction, 104(7), 1085–1099. https://doi.org/10.1111/j.1360-0443.2009.02564.x
   PubMed Web of Science ®Google Scholar
• Darke, S., Darke, S., Kaye, S., Darke, S., Kaye, S., McKetin, R., & Duflou, J. (2008). Major physical and psychological harms of methamphetamine use. Drug and Alcohol Review, 27(3), 253–262. https://doi.org/10.1080/09595230801923702
   PubMed Web of Science ®Google Scholar
• Dean, A. C., Groman, S. M., Morales, A. M., & London, E. D. (2013). An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans. Neuropsychopharmacology, 38(2), 259–274. https://doi.org/10.1038/npp.2012.179
   PubMed Web of Science ®Google Scholar
• Degenhardt, L., Hall, W., Warner-Smith, M., & Lynskey, M. (2004). Illicit drug use. Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors, 1, 1109–1176.
   Google Scholar
• Diefenbach, G. J., Woolley, S. B., & Goethe, J. W. (2009). The association between self-reported anxiety symptoms and suicidality. Journal of Nervous & Mental Disease, 197(2), 92–97. https://doi.org/10.1097/NMD.0b013e318196127c
   PubMed Web of Science ®Google Scholar
• Friedland, G. (2010). Infectious disease comorbidities adversely affecting substance users with HIV: Hepatitis C and tuberculosis. JAIDS Journal of Acquired Immune Deficiency Syndromes, 55(Suppl Suppl. 1), S37–42. https://doi.org/10.1097/QAI.0b013e3181f9c0b6
   PubMedGoogle Scholar
• Glasner-Edwards, S., Mooney, L. J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R. A. (2010). Psychopathology in methamphetamine-dependent adults 3 years after treatment. Drug and Alcohol Review, 29(1), 12–20. https://doi.org/10.1111/j.1465-3362.2009.00081.x
   PubMed Web of Science ®Google Scholar
• Herrmann, E. S., Matusiewicz, A. K., Stitzer, M. L., Higgins, S. T., Sigmon, S. C., & Heil, S. H. (2017). Contingency Management Interventions for HIV, Tuberculosis, and Hepatitis Control Among Individuals With Substance Use Disorders: A Systematized Review. J Subst Abuse Treat,72, 117–125.   h ttps://d oi.o rg/1 0.1016/j.jsat.2016.06.009
   PubMed Web of Science ®Google Scholar
• Hogle, J. M., & Curtin, J. J. (2006). Sex differences in negative affective response during nicotine withdrawal. Psychophysiology, 43(4), 344–356. https://doi.org/10.1111/j.1469-8986.2006.00406.x
   PubMed Web of Science ®Google Scholar
• Intachakra, S. (2012). Politeness motivated by the ‘heart’ and ‘binary rationality’ in Thai culture. Journal of Pragmatics, 44(5), 619–635. https://doi.org/10.1016/j.pragma.2011.07.016
   Web of Science ®Google Scholar
• Isaac, V., Wu, C.-Y., McLachlan, C. S., & Lee, M.-B. (2018). Associations between health-related self-efficacy and suicidality. BMC Psychiatry, 18(1), 126. h ttps://d oi.o rg/d oi:1 0.1186/s12888-018-1705-z
   PubMedGoogle Scholar
• Johnston, L. D., O’Malley, P. M., & Bachman, J. G. (2001). Monitoring the future national survey results on drug use, 1975–2000. In M. Bethesda (Ed.), National Institute on drug abuse. Secondary School Students (Vol. 1 (NIH publication 01-4924)).
   Google Scholar
• Kanato, M., & Leyatikul, P. (2017). Effectiveness of drug camps in treatment of substance abuse in Thailand. Journal of Community Health, 42(6), 1090–1095. https://doi.org/10.1007/s10900-017-0356-1
   PubMed Web of Science ®Google Scholar
• Komin, S. (1998). The world view through Thai value systems. In A. Pongsapich (Ed.), Traditional and changing Thai World view (pp. 209–297). Bangkok: Chulalongkorn University Press.
   Google Scholar
• Lovibond, S. H., & Lovibond, P. F. (1995). In manual for the depression anxiety stress scales. Psychology Foundation of Australia.
   Google Scholar
• McGregor, C., Srisurapanont, M., Jittiwutikarn, J., Laobhripatr, S., Wongtan, T., & White, J. M. (2005). The nature, time course and severity of methamphetamine withdrawal. Addiction, 100(9), 1320–1329. https://doi.org/10.1111/j.1360-0443.2005.01160.x
   PubMed Web of Science ®Google Scholar
• McLellan, A. T. (2017). Substance Misuse and Substance use Disorders: Why do they Matter in Healthcare? Transactions of the American Clinical and Climatological Association,128, 112–130.
   PubMedGoogle Scholar
• Merline, A. C., O’Malley, P. M., Schulenberg, J. E., Bachman, J. G., & Johnston, L. D. (2004). Substance use among adults 35 years of age: Prevalence, adulthood predictors, and impact of adolescent substance use. American Journal of Public Health, 94(1), 96–102. https://doi.org/10.2105/ajph.94.1.96
   PubMed Web of Science ®Google Scholar
• Milani, R. M., Parrott, A. C., Turner, J. J., & Fox, H. C. (2004). Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco users, and nondrug users. Addictive Behaviors, 29(5), 965–971. https://doi.org/10.1016/j.addbeh.2004.02.044
   PubMed Web of Science ®Google Scholar
• Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
   PubMed Web of Science ®Google Scholar
• National AIDS Prevention and Alleviation Committee. (2010). UNGASS Country progress report Thailand: Reporting period, January 2008-December 2009. National AIDS Management Center. https://data.unaids.org/pub/report/2010/thailand_2010_country_progress_report_en.pdf
   Google Scholar
• Onyeka, I. N., Beynon, C. M., Uosukainen, H., Korhonen, M. J., Ilomäki, J., Bell, J. S., Paasolainen, M., Tasa, N., Tiihonen, J., & Kauhanen, J. (2013). Coexisting social conditions and health problems among clients seeking treatment for illicit drug use in Finland: The HUUTI study. BMC Public Health, 13(1), 380. https://doi.org/10.1186/1471-2458-13-380
   PubMedGoogle Scholar
• Osman, A., Bagge, C. L., Gutierrez, P. M., Konick, L. C., Kopper, B. A., & Barrios, F. X. (2001). The Suicidal Behaviors Questionnaire-Revised (SBQ-R): Validation with clinical and nonclinical samples. Assessment, 8(4), 443–454. https://doi.org/10.1177/107319110100800409
   PubMed Web of Science ®Google Scholar
• Panenka, W. J., Procyshyn, R. M., Lecomte, T., MacEwan, G. W., Flynn, S. W., Honer, W. G., & Barr, A. M. (2013). Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings. Drug and Alcohol Dependence, 129(3), 167–179. https://doi.org/10.1016/j.drugalcdep.2012.11.016
   PubMed Web of Science ®Google Scholar
• Pape, H., Hammer, T., & Vaglum, P. (1994). Are “Traditional” sex differences less conspicuous in young Cannabis users than in other young people? Journal of Psychoactive Drugs, 26(3), 257–263. https://doi.org/10.1080/02791072.1994.10472439
   PubMed Web of Science ®Google Scholar
• Peltzer, K. (2018). Tuberculosis non-communicable disease comorbidity and multimorbidity in public primary care patients in South Africa. African Journal of Primary Health Care & Family Medicine, 10(1), e1–e6. https://doi.org/10.4102/phcfm.v10i1.1651
   PubMed Web of Science ®Google Scholar
• Sareen, J., Houlahan, T., Cox, B. J., & Asmundson, G. J. (2005). Anxiety disorders associated with suicidal ideation and suicide attempts in the National Comorbidity Survey. Journal of Nervous & Mental Disease, 193(7), 450–454. https://doi.org/10.1097/01.nmd.0000168263.89652.6b
   PubMed Web of Science ®Google Scholar
• Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, J. H., & Grant, I. (2007). Neurocognitive effects of methamphetamine: A critical review and meta-analysis. Neuropsychology Review, 17(3), 275–297. https://doi.org/10.1007/s11065-007-9031-0
   PubMed Web of Science ®Google Scholar
• Srisurapanont, M., Lamyai, W., Pono, K., Indrakamhaeng, D., Saengsin, A., Songhong, N., Khuwuthyakorn, P., & Jantamo, P. (2020). Cognitive impairment in methamphetamine users with recent psychosis: A cross-sectional study in Thailand. Drug and Alcohol Dependence, 210, 107961. https://doi.org/10.1016/j.drugalcdep.2020.107961
   PubMed Web of Science ®Google Scholar
• Suttajit, S., Kittirattanapaiboon, P., Junsirimongkol, B., Likhitsathian, S., & Srisurapanont, M. (2012). Risks of major depressive disorder and anxiety disorders among Thais with alcohol use disorders and illicit drug use: Findings from the 2008 Thai National Mental Health survey. Addictive Behaviors, 37(12), 1395–1399. h ttps://d oi.o rg/d oi:1 0.1016/j.addbeh.2012.06.014
   PubMed Web of Science ®Google Scholar
• Tran, T. D., Tran, T., & Fisher, J. (2013). Validation of the depression anxiety stress scales (DASS) 21 as a screening instrument for depression and anxiety in a rural community-based cohort of northern Vietnamese women. BMC Psychiatry, 13(1), 24. https://doi.org/10.1186/1471-244x-13-24
   PubMedGoogle Scholar
• Wakabayashi, M., McKetin, R., Banwell, C., Yiengprugsawan, V., Kelly, M., Sam-ang., S., Iso, H., & Sleigh, A., & Thai Cohort Study Team. (2015). Alcohol consumption patterns in Thailand and their relationship with non-communicable disease. BMC Public Health, 15(1), 1297. https://doi.org/10.1186/s12889-015-2662-9
   PubMedGoogle Scholar
• Wang, C. W., Chuang, H. Y., Chiang, H. C., Huang, P. C., Yu, M. L., & Dai, C. Y. (2019). Risk of hepatitis C virus infection in injecting and noninjecting drug users receiving opioid substitution therapy. J Chin Med Assoc,83(5), 454–460. h ttps://d oi.o rg/1 0.1097/jcma.0000000000000312
   Web of Science ®Google Scholar
• WHO expert consultation. (2004). Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. The Lancet, 363(9403), 157–163. https://doi.org/10.1016/s0140-6736(03)15268-3
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2014. Mental health and substance abuse -suicide data. http://www.who.int/mental_health/prevention/suicide/suicideprevent/en/
   Google Scholar
• Zhang, Y., Lu, C., Zhang, J., Hu, L., Song, H., Li, J., & Kang, L. (2013). Gender differences in abusers of amphetamine-type stimulants and ketamine in southwestern China. Addictive Behaviors, 38(1), 1424–1430. https://doi.org/10.1016/j.addbeh.2012.06.024
   PubMed Web of Science ®Google Scholar
• Zweben, J. E., Cohen, J. B., Christian, D., Galloway, G. P., Salinardi, M., Parent, D., & Iguchi, M. (2004). Psychiatric symptoms in methamphetamine users. American Journal on Addictions, 13(2), 181–190. https://doi.org/10.1080/10550490490436055
   PubMed Web of Science ®Google Scholar